Join
Live feed
·
INSIDERFilingvia Quantisnow
Karyopharm Therapeutics Inc. logo

EVP, CLO&Secretary Mano Michael was granted 700 shares and sold $2,527 worth of shares (266 units at $9.50), increasing direct ownership by 0.46% to 94,398 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KPTI (Karyopharm Therapeutics Inc.) and more on Quantisnow.